A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

NCT06789445 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Photoreceptor Disease
Retinitis Pigmentosa (RP)
Usher Syndrome
Inherited Retinal Disease (IRD)
Rod-Cone Dystrophy
Rod-Cone Disease
Retinal Degeneration
Cone-Rod Disease (C-RD)
Cone-Rod Dystrophy

Interventions

BIOLOGICAL: OpCT-001
BIOLOGICAL: OpCT-001

Sponsor

BlueRock Therapeutics